EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
- PMID: 30880632
- PMCID: PMC6732869
- DOI: 10.1177/2045894019841990
EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
Abstract
Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.
Figures
Similar articles
-
Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?J Heart Lung Transplant. 2021 Jul;40(7):614-622. doi: 10.1016/j.healun.2021.03.022. Epub 2021 Apr 2. J Heart Lung Transplant. 2021. PMID: 33962868 Free PMC article.
-
Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension.Int J Cardiovasc Imaging. 2020 Oct;36(10):1831-1843. doi: 10.1007/s10554-020-01897-3. Epub 2020 May 27. Int J Cardiovasc Imaging. 2020. PMID: 32462450 Free PMC article.
-
Endothelin-A receptor blockade in porcine pulmonary hypertension.Pediatr Res. 2002 Dec;52(6):913-21. doi: 10.1203/00006450-200212000-00017. Pediatr Res. 2002. PMID: 12438670
-
Pulmonary vascular resistance index: Getting the units right and why it matters.Clin Cardiol. 2019 Mar;42(3):334-338. doi: 10.1002/clc.23151. Epub 2019 Feb 27. Clin Cardiol. 2019. PMID: 30614019 Free PMC article. Review.
-
Haemodynamic evaluation of pulmonary hypertension.Eur Respir J. 2002 Nov;20(5):1314-31. doi: 10.1183/09031936.02.00068002. Eur Respir J. 2002. PMID: 12449189 Review.
Cited by
-
Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT.Radiology. 2024 Feb;310(2):e231718. doi: 10.1148/radiol.231718. Radiology. 2024. PMID: 38319169
-
Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.Eur Respir J. 2024 Mar 14;63(3):2300846. doi: 10.1183/13993003.00846-2023. Print 2024 Mar. Eur Respir J. 2024. PMID: 38302154 Free PMC article.
-
Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients.Medicina (Kaunas). 2023 Dec 28;60(1):58. doi: 10.3390/medicina60010058. Medicina (Kaunas). 2023. PMID: 38256318 Free PMC article. Review.
-
Clinical-radiological-pathological correlation in chronic thromboembolic pulmonary hypertension.Eur Respir Rev. 2023 Dec 20;32(170):230149. doi: 10.1183/16000617.0149-2023. Print 2023 Dec 31. Eur Respir Rev. 2023. PMID: 38123236 Free PMC article.
-
Clinical-radiological-pathological correlation in pulmonary arterial hypertension.Eur Respir Rev. 2023 Dec 20;32(170):230138. doi: 10.1183/16000617.0138-2023. Print 2023 Dec 31. Eur Respir Rev. 2023. PMID: 38123231 Free PMC article. Review.
References
-
- Kiely DG, Elliot CA, Sabroe I, et al. Pulmonary hypertension: diagnosis and management. BMJ 2013; 346: f2028. - PubMed
-
- Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; ▪: ERJ–2015. - PubMed
-
- Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed) 2016; 69: 177. - PubMed
-
- Hurdman J, Condliffe R, Elliot CA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. The European respiratory journal 2013; 41: 1292–1301. - PubMed
-
- Hurdman J, Condliffe R, Elliot CA, et al. Aspire Registry: assessing the spectrum of pulmonary hypertension identified at a referral centre. Eur Respir J 2011; ▪: ▪. - PubMed
